Ace Therapeutics stands as a premier preclinical contract service provider dedicated to driving drug development in the field of gastroenterology & hepatology. Our expertise lies in understanding disease mechanisms and drug targets, enabling us to deliver holistic solutions for a broad spectrum of digestive system disorders. We offer comprehensive drug development services, from target identification and validation to preclinical testing.
Types of Drugs | Service Details |
---|---|
Small Molecule Compound Development | We have expertise in designing and synthesizing small molecule compounds that target specific pathways involved in digestive disorders. |
Hormone Drug Development | Our team is skilled at formulating and optimizing hormone-based drugs to regulate digestive system functions and address hormonal imbalances related to gastrointestinal disorders. |
Interferon Drug Development | We have experience developing interferon-based drugs, which play a crucial role in modulating the immune response and treating conditions such as viral hepatitis and inflammatory bowel disease. |
Antibody Development | Our capabilities extend to antibody development, where we harness the power of targeted antibodies to selectively bind to disease-specific antigens, offering potential therapeutic options for digestive disorders. |
Nucleic Acid Drug Development | We possess expertise in nucleic acid-based drug development, including RNA interference (RNAi) and antisense oligonucleotide (ASO) technologies, which hold promise in regulating gene expression and targeting specific disease-causing genes in digestive disorders. |
Compound Synthesis
Through advanced synthetic organic chemistry techniques, our lab is able to help customers efficiently design and optimize small molecule libraries targeting specific digestive disease pathways.
Protein Expression & Purification
Leveraging mammalian, bacterial and baculovirus cell-based systems, we can express and purify recombinant proteins involved in disease processes.
Pharmacodynamic Research
We utilize both in vitro and in vivo models to investigate the pharmacodynamic properties of potential drug candidates.
Pharmacokinetic Research
Through integrated analytical techniques and validated bioanalytical methods, we can conduct thorough PK assessments to help you understand ADME properties.
Toxicology Research
Our rigorous and specialized safety assessment strategies fully evaluate the lead candidates' toxicological profiles.
At Ace Therapeutics, our experts combine extensive scientific knowledge with state-of-the-art technologies to accelerate the drug development process and bring effective treatments to market faster. If you're looking to optimize candidates or seeking collaboration, please contact us and discover how we can help advance your digestive disease drug development initiatives.
Our products and services are for research use only and can not be used for diagnostic or other purposes.